The GI Genius system was the first commercially available computer-aided detection (
Medtronic also announced its collaboration with Cosmo and Modernizing Medicine (ModMed), a pioneer in healthcare technology and Electronic Health Records (EHR), further emphasizing its commitment to a synergistic approach to the future of endoscopic care. ModMed's gGastro EHR software is complementary to the GI Genius system, offering robust documentation solutions.
'Through our collaboration with ModMed, we can continue to help gastroenterologists achieve greater efficiency by streamlining workflows and leveraging augmented decision-making, freeing up valuable time for patient care,' said
'The new developments at Cosmo on the GI Genius system, and specifically the release of the new operating system coped with ColonPROsoftware, will accelerate the introduction of new features and streamline the development of the AI Access platform,' said
The companies will begin testing out new capabilities for future integration, moving closer to their shared vision of enabling gGastro EHR software to receive real-time, AI-generated data from the GI Genius system, making the documentation process more efficient and enabling physicians to spend more of their time on patient care. Medtronic's announcements at the Genius Summit 2024 underscore its dedication to advancing colorectal cancer care with AI innovations and strategic collaborations. Cosmo and Medtronic remain at the forefront of delivering solutions that address the needs of patients and physicians alike.
About Cosmo
Cosmo is a pharmaceutical company focused on developing and commercialising products to treat selected gastrointestinal disorders, to improve endoscopy quality measures through aiding the detection of colonic lesions and to treat selected dermatological conditions. Cosmo develops and manufactures products which are distributed globally by selected partners including Lialda/ Mezavant/ Mesavancol, Uceris/ Cortiment, Aemcolo/ Relafalk and Winlevi. Cosmo has also developed medical devices for endoscopy and has a partnership with Medtronic for the global distribution of GI Genius which uses artificial intelligence to help detect potential signs of colon cancer. The company also has a rich development pipeline.
Contact:
Tel: +353 1 817 03 70
Email: hwinchester@cosmopharma.com
Disclaimer
Some of the statements in this press release may be forward-looking statements or statements of future expectations based on currently available information. Such statements are naturally subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. Cosmo does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such statements. Therefore, in no case whatsoever will Cosmo and its affiliate companies be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.
(C) 2024 Electronic News Publishing, source